The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.

Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma. Clinical Cancer Research , 2023 ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Men around the world dealing with sexual impotence have been treated for years with the drug sildenafil, sold under brand ...

Scientists have pinpointed a crucial network of immune cells that allows humans to digest food safely without triggering ...

Follicular dendritic cell sarcoma in the right chest wall Hongli X and others Medicine (Baltimore), 2020. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Diakonos Oncology’s dendritic cell immunotherapy previously received Fast Track designation for glioblastoma multiforme. Results from a phase 1 trial (ClinicalTrials.gov Identifier: ...

1. Identify the key roles of dendritic cells in cancer immunotherapy, including their use as antigen-loaded vaccines and intratumoral adjuvants. 2. Explain the strategies used to overcome tumor ...

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a type of blood cancer that affects immune system cells. It most often affects the skin but can also involve bone marrow and other cell types.

Dubodencel, also known as DOC1021, is a first-in-class, double-loaded autologous dendritic cell therapy that uniquely combines tumor lysate and amplified tumor-derived mRNA.

The study aims to uncover the immunological basis of Tanshi (phlegm-dampness) constitution—a subhealth type in traditional Chinese medicine ...